Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ram

Showing results (391-400 of 24,158) with videos related to

Pageof 2,416
Sort By:
ACS Medicinal Chemistry Letters|November 19, 2025
Novel Bicyclic Heterocycles as MRGPRX2 Antagonists for Treating Inflammatory DiseasesRam W Sabnis
ACS Medicinal Chemistry Letters|November 19, 2025
Novel Tricyclic Compounds as TLR7 Agonists for Treating CancerRam W Sabnis
ACS Medicinal Chemistry Letters|November 19, 2025
Novel Compounds as TREM2 Agonists for Treating Alzheimer's DiseaseRam W Sabnis
ACS Medicinal Chemistry Letters|January 14, 2026
Novel Compounds for Treating Hemoglobinopathies, Namely, Anemia, Sickle Cell Disease, or ThalassemiaRam W Sabnis
ACS Medicinal Chemistry Letters|January 14, 2026
Novel Imidazopyridazine Compounds as IL-17 Inhibitors for Treating Inflammatory DiseasesRam W Sabnis
ACS Medicinal Chemistry Letters|January 14, 2026
Novel Compounds as Glucagon Receptor Agonists for Treating Type 2 Diabetes Mellitus and ObesityRam W Sabnis
ACS Medicinal Chemistry Letters|February 18, 2026
Novel Compounds as LPAR1 Inhibitors for Treating Systemic SclerosisRam W Sabnis
ACS Medicinal Chemistry Letters|February 18, 2026
Novel Compounds for Treating HemoglobinopathiesRam W Sabnis
Sensors (Basel, Switzerland)|October 16, 2025
Advancing Land Monitoring Through Synergistic Harmonization of Optical, Radar and Lidar Satellite TechnologiesRam C Sharma
ACS Medicinal Chemistry Letters|September 17, 2025
Novel Tricyclic Compounds as ERK5 Inhibitors for Treating CancerRam W Sabnis
Pageof 2,416

Showing results (391-400 of 24,158) with videos related to

Sort By:
Pageof 2,416
ACS Medicinal Chemistry Letters|November 19, 2025
Novel Bicyclic Heterocycles as MRGPRX2 Antagonists for Treating Inflammatory DiseasesRam W Sabnis
ACS Medicinal Chemistry Letters|November 19, 2025
Novel Tricyclic Compounds as TLR7 Agonists for Treating CancerRam W Sabnis
ACS Medicinal Chemistry Letters|November 19, 2025
Novel Compounds as TREM2 Agonists for Treating Alzheimer's DiseaseRam W Sabnis
ACS Medicinal Chemistry Letters|January 14, 2026
Novel Compounds for Treating Hemoglobinopathies, Namely, Anemia, Sickle Cell Disease, or ThalassemiaRam W Sabnis
ACS Medicinal Chemistry Letters|January 14, 2026
Novel Imidazopyridazine Compounds as IL-17 Inhibitors for Treating Inflammatory DiseasesRam W Sabnis
ACS Medicinal Chemistry Letters|January 14, 2026
Novel Compounds as Glucagon Receptor Agonists for Treating Type 2 Diabetes Mellitus and ObesityRam W Sabnis
ACS Medicinal Chemistry Letters|February 18, 2026
Novel Compounds as LPAR1 Inhibitors for Treating Systemic SclerosisRam W Sabnis
ACS Medicinal Chemistry Letters|February 18, 2026
Novel Compounds for Treating HemoglobinopathiesRam W Sabnis
Sensors (Basel, Switzerland)|October 16, 2025
Advancing Land Monitoring Through Synergistic Harmonization of Optical, Radar and Lidar Satellite TechnologiesRam C Sharma
ACS Medicinal Chemistry Letters|September 17, 2025
Novel Tricyclic Compounds as ERK5 Inhibitors for Treating CancerRam W Sabnis
Pageof 2,416